BWL
LGND icon

Bogart Wealth LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Bogart Wealth LLC’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69K Hold
18
– – ﹤0.01% 1165
2026
Q1 		$3.59K Hold
18
– – ﹤0.01% 1147
2025
Q4 		$3.4K Hold
18
– – ﹤0.01% 1078
2025
Q3 		$3.19K Hold
18
– – ﹤0.01% 1055
2025
Q2 		$2.05K Hold
18
– – ﹤0.01% 1102
2025
Q1 		$1.89K Sell
18
-19
-51% -$2.15K ﹤0.01% 1081
2024
Q4 		$3.96K Buy
+37
New +$4.18K ﹤0.01% 943
2022
Q4 		– Sell
-16
Closed -$1K – 1133
2022
Q3 		$1K Buy
+16
New +$941 ﹤0.01% 913

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bogart Wealth LLC's LGND Position: Q2 2026 in Review

Bogart Wealth LLC held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 18 shares worth $5.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Bogart Wealth LLC first reported a position in LGND in Q3 2022 and has held it in 8 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Bogart Wealth LLC held 18 shares of Ligand Pharmaceuticals worth $5.69K as of Q2 2026.
  • Bogart Wealth LLC left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1165 holding.
  • Bogart Wealth LLC first reported a position in Ligand Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.